Literature DB >> 25062456

Preoperative neck ultrasound in clinical node-negative differentiated thyroid cancer.

Laura Y Wang1, Frank L Palmer, Dorothy Thomas, Ashok R Shaha, Jatin P Shah, Snehal G Patel, R Michael Tuttle, Ian Ganly.   

Abstract

BACKGROUND: The impact of preoperative neck ultrasound (US) on management of the lateral neck in patients with differentiated thyroid cancer is unclear. The objective of this study was to assess the impact of preoperative neck US on the rate of lateral neck dissection in clinical N0 neck and initial response to therapy.
METHODS: An institutional review board-approved retrospective review of 890 patients that had thyroid surgery for differentiated thyroid cancer between 2009 and 2010 was performed at our institution. Patients with palpable neck disease, distant metastases, less than total thyroidectomy, no postoperative thyroglobulin (Tg) determinations, and positive Tg antibodies were excluded, leaving 465 patients available for analysis. Patients were divided into those who had a preoperative neck US to evaluate lateral neck nodes (n = 234) and those who did not (n = 231). Patient and tumor characteristics were compared using the χ(2) test. The primary end point was response to therapy, defined by postoperative US and Tg levels.
RESULTS: There were no significant differences in age, histology, T stage, postoperative radioactive iodine dose, American Joint Committee on Cancer stage, American Thyroid Association risk category, or duration of follow up between the 2 groups. Patients with preoperative neck US were more likely to have lateral neck dissection compared with patients without preoperative neck US [n = 31 (13.2%) vs n = 2 (0.9%); P < .001]. Preoperative neck US resulted in a better response to therapy (P = 0.005), a greater likelihood of no evidence of disease, and a smaller likelihood of having a biochemical or structural incomplete response or a return for delayed neck dissection. The preoperative US group also resulted in fewer recurrences; 10 patients from the no preoperative US group returned to the operating room compared with two patients (4.3% vs 0.9%, P = .018) who had a preoperative neck US.
CONCLUSION: Preoperative neck US detects more lateral neck disease, leading to an increase in lateral neck dissection with subsequent improvement in response to therapy and fewer return to the operating room for regional recurrence management.

Entities:  

Mesh:

Year:  2014        PMID: 25062456     DOI: 10.1210/jc.2014-1681

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Optimal differentiated thyroid cancer management in the elderly.

Authors:  Donald S A McLeod; Kelly Carruthers; Dev A S Kevat
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

Review 2.  Post-treatment surveillance of thyroid cancer.

Authors:  L Y Wang; I Ganly
Journal:  Eur J Surg Oncol       Date:  2017-07-19       Impact factor: 4.424

Review 3.  Nodal metastases in thyroid cancer: prognostic implications and management.

Authors:  Laura Y Wang; Ian Ganly
Journal:  Future Oncol       Date:  2016-03-07       Impact factor: 3.404

4.  Cost-effectiveness analysis of papillary thyroid cancer surveillance.

Authors:  Laura Y Wang; Benjamin R Roman; Jocelyn C Migliacci; Frank L Palmer; R Michael Tuttle; Ashok R Shaha; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal:  Cancer       Date:  2015-08-17       Impact factor: 6.860

5.  Effectiveness of routine ultrasonographic surveillance of patients with low-risk papillary carcinoma of the thyroid.

Authors:  Laura Y Wang; Benjamin R Roman; Frank L Palmer; R Michael Tuttle; Ashok R Shaha; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal:  Surgery       Date:  2015-12-31       Impact factor: 3.982

6.  Pre-operative serum TSH levels: A risk factor for advanced metastatic differentiated thyroid carcinoma.

Authors:  Sumera Batool; Muhammad Shakir Afridi; Adeel Khoja; Najmul Islam
Journal:  Pak J Med Sci       Date:  2019 Sep-Oct       Impact factor: 1.088

7.  Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid Cancer.

Authors:  Ali S Alzahrani; Yosra Moria; Noha Mukhtar; Hadeel Aljamei; Sedra Mazi; Lina Albalawi; Abeer Aljomaiah
Journal:  J Endocr Soc       Date:  2020-11-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.